NanoCell is dedicated to advancing womens reproductive health through biopharmaceutical technologies. The companys proprietary intrauterine treatment significantly improves embryo implantation, thereby increasing the chances of conception. NanoCell is developing a method, kit, and composition for increasing the implantation rate of embryos in both humans and livestock using enzymatically remodeled extra-cellular matrix (ECM) to improve the efficiency of embryo implantation.